0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Ideas and Opinions |

Implementation of a New Screening Recommendation in Health Care: The Veterans Health Administration's Approach to Lung Cancer ScreeningImplementation of a New Screening Recommendation in Health Care

Linda S. Kinsinger, MD, MPH; David Atkins, MD, MPH; Dawn Provenzale, MD, MS; Charles Anderson, MD, PhD; and Robert Petzel, MD
[+] Article and Author Information

This article was published online first at www.annals.org on 12 August 2014.


From the Veterans Health Administration, Washington, DC.

Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-1070.

Requests for Single Reprints: Linda S. Kinsinger, MD, MPH, National Center for Health Promotion and Disease Prevention, Veterans Health Administration, 3022 Croasdaile Drive, Suite 200, Durham, NC 27705; e-mail, Linda.Kinsinger@va.gov.

Current Author Addresses: Dr. Kinsinger: National Center for Health Promotion and Disease Prevention, Veterans Health Administration, 3022 Croasdaile Drive, Suite 200, Durham, NC 27705.

Dr. Atkins: Office of Research and Development, 810 Vermont Avenue Northwest (10P9H), Washington, DC 20420.

Dr. Provenzale: Durham Veterans Affairs Medical Center, 508 Fulton Street (152), Durham, NC 27705.

Dr. Anderson: Diagnostic Services, Office of Patient Care Services, Veterans Health Administration, 3022 Croasdaile Drive, Suite 100, Durham, NC 27705.

Dr. Petzel: 4621 East Lake Harriet Parkway Minneapolis, MN 55419.

Author Contributions: Conception and design: L.S. Kinsinger, D. Atkins, D. Provenzale.

Drafting of the article: L.S. Kinsinger, D. Atkins.

Critical revision of the article for important intellectual content: L.S. Kinsinger, D. Atkins, D. Provenzale, C. Anderson.

Final approval of the article: L.S. Kinsinger, D. Atkins, D. Provenzale, C. Anderson, R. Petzel.

Administrative, technical, or logistic support: L.S. Kinsinger.

Collection and assembly of data: D. Provenzale.


Ann Intern Med. 2014;161(8):597-598. doi:10.7326/M14-1070
Text Size: A A A

This commentary describes the Veterans Health Administration's demonstration project that aims to assess initial experience in implementing lung screening programs at select sites. It will assess the results to inform whether, and how, to proceed with broader implementation.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Low-dose computed tomography is considerable for lung cancer screening in China
Posted on September 8, 2014
Xin-Zu Chen; Rui Wang; Jian-Kun Hu
Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China
Conflict of Interest: None Declared
To the editor:

Kinsinger and et al. discussed the new recommendation by Veterans Health Administration, U.S. on low-dose computed tomography (LDCT) for lung cancer screening, and accept LDCT as an exciting opportunity to reduce mortality from lung cancer (1). Lung cancer is always the leading cause of cancer death in China and induces heavy healthcare burden. Compared with U.S. and Germany, 5-year prevalence of colorectal cancer in China (55.2/100,000 persons) is lower than those in U.S. (106.4/100,000 persons) and Germany (78.5/100,000 persons) (2). Nevertheless, mortality-to-prevalence ratio of lung cancer is as high as 0.59 in China, compared to only 0.27 and 0.28 in U.S. and Germany, respectively (2). It indicates the overall survival outcome of lung cancer is apparently worse in China, despite of the lower prevalence.

This unfavorable situation has to attribute to that most Chinese patients with lung cancer are diagnosed at symptomatic stage, but few at early stage (16%–22%). In 2003, Ministry of Health (MOH), China issued governmental outlines of China Cancer Prevention and Control Program (2004–2010). Thus, lung cancer has been defined as one out of eight key malignancies requiring intensive prevention and control in China, due to substantial healthcare burden from increasing mortality. However, screening and surveillance programs for lung cancer are merely implemented with loose organization in few major cities in China. In 2009, the government developed an affordable and accessible national healthcare insurance system covering both urban and rural residents, and including those eight key malignancies. In 2012, MOH launched an organized community-based screening project in 9 urban areas for 5 key malignancies. Despite of previous efforts of cancer prevention and control, mortality-to-incidence ratios of lung cancer were not decreased (0.91 in 2004 and 0.90 in 2012, respectively) (2).

Commonly, the screening examination for lung cancer is based on chest X-ray for many years in China. According to NLST trial, LDCT shows better performance for detecting early-stage lung cancer and is associated with decreased mortality from lung cancer (4). By now, many Chinese hospitals attempt to practise LDCT for lung cancer screening during health-checkup instead of traditional chest X-ray test. Regarding the poor survival outcome, it’s possibly cost-effective to establish organized nationwide screening and surveillance programs based on LDCT among high-risk population to improve overall survival outcome of lung cancer in China.

Conflicts of interest: None declared.

References
1. Kinsinger LS, Atkins D, Provenzale D, Anderson C, Petzel R. Implementation of a new screening recommendation in health care: The VHA's approach to lung cancer screening. Ann Intern Med. 2014. doi: 10.7326/M14-1070 [PMID: 25111673]
2. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr
3. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 4;365(5):395-409. [PMID: 21714641]
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)